Belzempic EZUSE – Semaglutide – 2mg – Prefilled Pen (int) Beligas

What Is Belzempic EZUSE Semaglutide? Semaglutide is a synthetic GLP-1 (glucagon-like peptide-1) receptor agonist peptide, structurally analogous to human incretin hormones, and engineered for extended plasma half-life via fatty-acid side-chain conjugation. The Belzempic EZUSE product from Beligas presents this compound in a precision-filled 2mg prefilled pen format, designed to support reproducible delivery accuracy in laboratory and in-vitro research settings. Researchers visiting uksteroidshops.co.uk will find this formulation sourced directly from Beligas, a manufacturer recognised for analytical documentation and consistent pharmaceutical-grade production standards. Research Applications and Scientific Context Semaglutide has attracted substantial scientific attention due to its potent, selective binding to GLP-1 receptors in pancreatic beta-cell and hypothalamic tissue models. Preclinical and clinical data demonstrate effects on glucose-stimulated insulin secretion, glucagon suppression, gastric emptying, and satiety signalling pathways. Researchers investigating metabolic syndrome, obesity biology, and type-2 diabetes mechanisms frequently evaluate GLP-1 receptor agonists as reference tools. The extended half-life of semaglutide (approximately 168 hours in human pharmacokinetic studies) distinguishes it from earlier GLP-1 analogues such as liraglutide, making it valuable for studies requiring prolonged receptor engagement models. Scientists exploring metabolic modulation may also find complementary reference material across the Fat Burners & Weight Loss category, where related metabolic compounds are catalogued for comparative research purposes. The prefilled pen format reduces preparatory steps associated with lyophilised peptide reconstitution, helping to maintain dose consistency across repeated experimental protocols. Each 2mg unit is manufactured under controlled conditions and supplied with batch-specific analytical documentation from Beligas. For laboratories that also examine androgenic hormone signalling alongside metabolic endpoints, reference compounds available in the oral steroids range or the injectable steroids section may provide useful comparative context when studying multi-pathway metabolic interactions. Product Specifications Belzempic EZUSE Semaglutide 2mg — Key Data Parameter Detail Compound Semaglutide Class GLP-1 Receptor Agonist Peptide CAS Number 910463-68-2 Molecular Formula C₁₈₄H₂₉₁N₄₅O₅₉ Molecular Weight 4113.58 g/mol Strength 2mg per pen Format Prefilled injection pen (EZUSE) Manufacturer Beligas Pharmaceuticals SKU EU12657 Storage 2–8°C refrigerated; protect from freezing and light Compliance and Safety Notice Belzempic EZUSE Semaglutide 2mg is supplied strictly for legitimate research and laboratory study purposes. This product is not intended for human consumption, self-administration, or clinical use outside of an approved research framework. Purchasers must be aged 18 or over and are solely responsible for ensuring compliance with all applicable local, regional, and national legislation governing the acquisition and use of research compounds. Nothing on this page constitutes medical advice, a treatment recommendation, or a substitute for guidance from a qualified healthcare professional.